CSMS #53307262
System MaintenanceLow urgency
FDA’s ITACS Planned Maintenance and Enhancement Saturday, September 17, 2022, 11:00 p.m. to Sunday, September 18, 2022, 2:00 a.m. ET
CSMS # 53307262 - FDA’s ITACS Planned Maintenance and Enhancement Saturday, September 17, 2022, 11:00 p.m. to Sunday, September 18, 2022, 2:00 a.m. ET
U.S. Customs and Border Protection sent this bulletin at 09/16/2022 04:00 PM EDT
CSMS # 53307262 - FDA’s ITACS Planned Maintenance and Enhancement Saturday, September 17, 2022, 11:00 p.m. to Sunday, September 18, 2022, 2:00 a.m. ET
Due to planned maintenance, FDA’s ITACS (Import Trade Auxiliary Communications System) and ITACS account management functionality will be unavailable Saturday September 17, 2022, 11:00 PM to Sunday September 18, 2022, 2:00 AM EDT.
If documents must be submitted during the downtime, they can be submitted to the local FDA office at the port of entry via that office’s preferred alternate communication method. Contact information for all FDA import offices can be found on FDA’s Import Offices and Ports of Entry web page:
Import Offices and Ports of Entry | FDA
.
Following the release ITACS will be able to provide authorized ITACS account holders a downloadable history of FDA Line Statuses and ITACS Statuses for selected entries/lines.
Note: If ITACS has not received arrival notification for truck and air shipments it will display the text 'FDA entry status information is not available pending receipt of Conveyance Arrival Notification.' in red and the history report will state 'No public status available'.
ITACS accounts can be requested via the FDA Unified Registration and Listing System (FURLS) at
FDA industry systems - Accounts management
for those who have not already created an account. Please follow the instructions provided in the ITACS Account Management Presentation at
ITACS | FDA
to request an account.
Questions regarding the maintenance window can be sent to ITACS Support at
ITACSSupport@fda.hhs.gov
.
Additional Information
Programs Affected:
ACE
PGAs Affected:
FDA